Thilo Werner

5PUBLICATIONS
127CO-AUTHORS
PharmacogenomicsMolecular targetsGene and molecular therapyHaematological tumoursBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 19, 2024
Synergistic Effects of PARP Inhibition and Cholesterol Biosynthesis Pathway Modulation.

Anna Rutkowska, H Christian Eberl, Thilo Werner

|Apr 08, 2024
Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells.

Gabriele Picco, Yanhua Rao, Angham Al Saedi

|May 27, 2021
BRD4 methylation by the methyltransferase SETD6 regulates selective transcription to control mRNA translation.

Zlata Vershinin, Michal Feldman, Thilo Werner

|Mar 21, 2020
Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation.

Omer Gilan, Inmaculada Rioja, Kathy Knezevic

|Jun 17, 2017
Click chemistry enables preclinical evaluation of targeted epigenetic therapies.

Dean S Tyler, Johanna Vappiani, Tatiana Cañeque

Pageof 1